MRI in the assessment of thyroid-associated orbitopathy activity

被引：12

作者：

Civrny, J. ^{[1
,2
]}

Karhanova, M. ^{[2
,3
]}

Hubnerova, P. ^{[2
,3
]}

Schovanek, J. ^{[2
,4
]}

Herman, M. ^{[1
,2
]}

机构：

[1] Palacky Univ, Dept Radiol, Olomouc, Czech Republic

[2] Univ Hosp, Olomouc, Czech Republic

[3] Palacky Univ, Dept Ophthalmol, Olomouc, Czech Republic

[4] Palacky Univ, Dept Internal Med Nephrol Rheumatol & Endocrinol, Olomouc, Czech Republic

来源：

CLINICAL RADIOLOGY | 2022年 / 77卷 / 12期

关键词：

CLINICAL ACTIVITY SCORE; GRAVES OPHTHALMOPATHY; EXTRAOCULAR-MUSCLES; SIGNAL INTENSITY; OPTIC NEUROPATHY; DISEASE-ACTIVITY; PATHOGENESIS; MANAGEMENT; FAT; PREDICTION;

D O I：

10.1016/j.crad.2022.08.124

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Management of patients with thyroid-associated orbitopathy (also called Graves' disease) is dependent on the assessment of the disease activity. Evaluation of disease activity is based on ophthalmological examination. Magnetic resonance imaging (MRI) is an auxiliary method that may help quantify the activity and is also helpful in obtaining anatomical information concerning muscle thickness, exophthalmos, or optic neuropathy. We present a review of MRI techniques of the orbits with emphasis on the evaluation of disease activity. The most convincing seems to be the group of T2-weighted techniques such as conventional T2 weighting, T2 relaxometry, and T2 mapping. Dynamic contrast-enhanced MRI is another promising method. (c) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：925 / 934

页数：10

共 43 条

[1] The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy [J].

Bartalena, L. ;

Kahaly, G. J. ;

Baldeschi, L. ;

Dayan, C. M. ;

Eckstein, A. ;

Marcocci, C. ;

Marino, M. ;

Vaidya, B. ;

Wiersinga, W. M. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (04) :G43-G67

[2]

Blandford AD, 2017, EXPERT REV OPHTHALMO, V12, P111, DOI 10.1080/17469899.2017.1276444

[3] Fat and Water Magnetic Resonance Imaging [J].

Bley, Thorsten A. ;

Wieben, Oliver ;

Francois, Christopher J. ;

Brittain, Jean H. ;

Reeder, Scott B. .

JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 31 (01) :4-18

[4] Evaluation of extraocular muscles in the edematous phase of graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging [J].

Cakirer, S ;

Cakirer, D ;

Basak, M ;

Durmaz, S ;

Altuntas, Y ;

Yigit, U .

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2004, 28 (01) :80-86

[5] Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk [J].

Chan, L. -L. ;

Tan, H. -E. ;

Fook-Chong, S. ;

Teo, T-H ;

Lim, L-H ;

Seah, L-L .

AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (03) :597-602

[6] Practical medical applications of quantitative MR relaxometry [J].

Cheng, Hai-Ling Margaret ;

Stikov, Nikola ;

Ghugre, Nilesh R. ;

Wright, Graham A. .

JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 36 (04) :805-824

[7]

Dalto Vitor Faeda, 2020, Radiol Bras, V53, P223, DOI 10.1590/0100-3984.2019.0077

[8] T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study [J].

Das, Tilak ;

Roos, Jonathan C. P. ;

Patterson, Andrew J. ;

Graves, Martin J. ;

Murthy, Rachna .

EYE, 2019, 33 (02) :235-243

[9] SIMPLE PROTON SPECTROSCOPIC IMAGING [J].

DIXON, WT .

RADIOLOGY, 1984, 153 (01) :189-194

[10]

Dudau Cristina, 2019, BJR Open, V1, P20180015, DOI 10.1259/bjro.20180015

← 1 2 3 4 5 →